RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Maria Figueiredo-Pereira to Proteasome Endopeptidase Complex

This is a "connection" page, showing publications Maria Figueiredo-Pereira has written about Proteasome Endopeptidase Complex.
  1. Huang H, Wang H, Figueiredo-Pereira ME. Regulating the ubiquitin/proteasome pathway via cAMP-signaling: neuroprotective potential. Cell Biochem Biophys. 2013 Sep; 67(1):55-66.
    View in: PubMed
    Score: 0.431
  2. Huang Q, Wang H, Perry SW, Figueiredo-Pereira ME. Negative regulation of 26S proteasome stability via calpain-mediated cleavage of Rpn10 subunit upon mitochondrial dysfunction in neurons. J Biol Chem. 2013 Apr 26; 288(17):12161-74.
    View in: PubMed
    Score: 0.417
  3. Myeku N, Wang H, Figueiredo-Pereira ME. cAMP stimulates the ubiquitin/proteasome pathway in rat spinal cord neurons. Neurosci Lett. 2012 Oct 11; 527(2):126-31.
    View in: PubMed
    Score: 0.402
  4. Metcalfe MJ, Huang Q, Figueiredo-Pereira ME. Coordination between proteasome impairment and caspase activation leading to TAU pathology: neuroprotection by cAMP. Cell Death Dis. 2012 Jun 21; 3:e326.
    View in: PubMed
    Score: 0.397
  5. Myeku N, Figueiredo-Pereira ME. Dynamics of the degradation of ubiquitinated proteins by proteasomes and autophagy: association with sequestosome 1/p62. J Biol Chem. 2011 Jun 24; 286(25):22426-40.
    View in: PubMed
    Score: 0.366
  6. Myeku N, Metcalfe MJ, Huang Q, Figueiredo-Pereira M. Assessment of proteasome impairment and accumulation/aggregation of ubiquitinated proteins in neuronal cultures. Methods Mol Biol. 2011; 793:273-96.
    View in: PubMed
    Score: 0.358
  7. Huang Q, Figueiredo-Pereira ME. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications. Apoptosis. 2010 Nov; 15(11):1292-311.
    View in: PubMed
    Score: 0.354
  8. Arnaud LT, Myeku N, Figueiredo-Pereira ME. Proteasome-caspase-cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells. J Neurochem. 2009 Jul; 110(1):328-42.
    View in: PubMed
    Score: 0.319
  9. Vernace VA, Schmidt-Glenewinkel T, Figueiredo-Pereira ME. Aging and regulated protein degradation: who has the UPPer hand? Aging Cell. 2007 Oct; 6(5):599-606.
    View in: PubMed
    Score: 0.283
  10. Vernace VA, Arnaud L, Schmidt-Glenewinkel T, Figueiredo-Pereira ME. Aging perturbs 26S proteasome assembly in Drosophila melanogaster. FASEB J. 2007 Sep; 21(11):2672-82.
    View in: PubMed
    Score: 0.276
  11. Wang Z, Aris VM, Ogburn KD, Soteropoulos P, Figueiredo-Pereira ME. Prostaglandin J2 alters pro-survival and pro-death gene expression patterns and 26 S proteasome assembly in human neuroblastoma cells. J Biol Chem. 2006 Jul 28; 281(30):21377-21386.
    View in: PubMed
    Score: 0.261
  12. Jean-Louis T, Rockwell P, Figueiredo-Pereira ME. Prostaglandin J2 promotes O-GlcNAcylation raising APP processing by a- and ?-secretases: relevance to Alzheimer's disease. Neurobiol Aging. 2018 02; 62:130-145.
    View in: PubMed
    Score: 0.144
  13. Boamah EK, Brekman A, Tomasz M, Myeku N, Figueiredo-Pereira M, Hunter S, Meyer J, Bhosle RC, Bargonetti J. DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1. Chem Res Toxicol. 2010 Jul 19; 23(7):1151-62.
    View in: PubMed
    Score: 0.087
  14. Ogburn KD, Figueiredo-Pereira ME. Cytoskeleton/endoplasmic reticulum collapse induced by prostaglandin J2 parallels centrosomal deposition of ubiquitinated protein aggregates. J Biol Chem. 2006 Aug 11; 281(32):23274-84.
    View in: PubMed
    Score: 0.065
  15. Li Z, Melandri F, Berdo I, Jansen M, Hunter L, Wright S, Valbrun D, Figueiredo-Pereira ME. Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition. Biochem Biophys Res Commun. 2004 Jul 09; 319(4):1171-80.
    View in: PubMed
    Score: 0.057
  16. Li Z, Arnaud L, Rockwell P, Figueiredo-Pereira ME. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells. J Neurochem. 2004 Jul; 90(1):19-28.
    View in: PubMed
    Score: 0.057
  17. Li Z, Jansen M, Pierre SR, Figueiredo-Pereira ME. Neurodegeneration: linking ubiquitin/proteasome pathway impairment with inflammation. Int J Biochem Cell Biol. 2003 May; 35(5):547-52.
    View in: PubMed
    Score: 0.053
  18. Oliveros G, Wallace CH, Chaudry O, Liu Q, Qiu Y, Xie L, Rockwell P, Figueiredo-Pereira ME, Serrano PA. Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation. Brain. 2023 03 01; 146(3):898-911.
    View in: PubMed
    Score: 0.052
  19. Figueiredo-Pereira ME, Li Z, Jansen M, Rockwell P. N-acetylcysteine and celecoxib lessen cadmium cytotoxicity which is associated with cyclooxygenase-2 up-regulation in mouse neuronal cells. J Biol Chem. 2002 Jul 12; 277(28):25283-9.
    View in: PubMed
    Score: 0.049
  20. Rockwell P, Yuan H, Magnusson R, Figueiredo-Pereira ME. Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2). Arch Biochem Biophys. 2000 Feb 15; 374(2):325-33.
    View in: PubMed
    Score: 0.042
  21. Korsmeyer KK, Davoll S, Figueiredo-Pereira ME, Correia MA. Proteolytic degradation of heme-modified hepatic cytochromes P450: A role for phosphorylation, ubiquitination, and the 26S proteasome? Arch Biochem Biophys. 1999 May 01; 365(1):31-44.
    View in: PubMed
    Score: 0.040
  22. Wang HF, Figueiredo Pereira ME, Correia MA. Cytochrome P450 3A degradation in isolated rat hepatocytes: 26S proteasome inhibitors as probes. Arch Biochem Biophys. 1999 May 01; 365(1):45-53.
    View in: PubMed
    Score: 0.040
  23. Figueiredo-Pereira ME, Cohen G. The ubiquitin/proteasome pathway: friend or foe in zinc-, cadmium-, and H2O2-induced neuronal oxidative stress. Mol Biol Rep. 1999 Apr; 26(1-2):65-9.
    View in: PubMed
    Score: 0.040
  24. Figueiredo-Pereira ME, Chen WE, Li J, Johdo O. The antitumor drug aclacinomycin A, which inhibits the degradation of ubiquitinated proteins, shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20 S proteasome. J Biol Chem. 1996 Jul 12; 271(28):16455-9.
    View in: PubMed
    Score: 0.033
  25. Figueiredo-Pereira ME, Chen WE, Yuan HM, Wilk S. A novel chymotrypsin-like component of the multicatalytic proteinase complex optimally active at acidic pH. Arch Biochem Biophys. 1995 Feb 20; 317(1):69-78.
    View in: PubMed
    Score: 0.030
  26. Figueiredo-Pereira ME, Berg KA, Wilk S. A new inhibitor of the chymotrypsin-like activity of the multicatalytic proteinase complex (20S proteasome) induces accumulation of ubiquitin-protein conjugates in a neuronal cell. J Neurochem. 1994 Oct; 63(4):1578-81.
    View in: PubMed
    Score: 0.029
  27. Figueiredo-Pereira ME, Banik N, Wilk S. Comparison of the effect of calpain inhibitors on two extralysosomal proteinases: the multicatalytic proteinase complex and m-calpain. J Neurochem. 1994 May; 62(5):1989-94.
    View in: PubMed
    Score: 0.028
  28. Figueiredo-Pereira ME, Yu B, Wilk S. Dissociation and reassociation of the bovine pituitary multicatalytic proteinase complex. J Biol Chem. 1994 Jan 07; 269(1):621-6.
    View in: PubMed
    Score: 0.028
  29. Wilk S, Figueiredo-Pereira ME. Synthetic inhibitors of the multicatalytic proteinase complex (proteasome). Enzyme Protein. 1993; 47(4-6):306-13.
    View in: PubMed
    Score: 0.026
  30. Gregori L, Fuchs C, Figueiredo-Pereira ME, Van Nostrand WE, Goldgaber D. Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro. J Biol Chem. 1995 Aug 25; 270(34):19702-8.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support